Trial Details

COMPLETED
Basic Information
Clinical ID c1558
Identifier NCT02261636
Trial Title Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: mesalazine
Participant Information
Sponsor Ferring Pharmaceuticals
City Zutphen
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-01-15
Primary Completion Date 2019-01-14
Completion Date 2019-01-14